Vaccination against SARS-CoV-2 in Patients with Inflammatory Bowel Diseases: Where Do We Stand?

Crohn’s disease and ulcerative colitis are chronic inflammatory bowel diseases (IBDs). Immunosuppressive medication is the main therapeutic approach to reducing inflammation of the gastrointestinal tract. Immunocompromised patients are more vulnerable to severe courses of illness after infection wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Tepasse, Phil-Robin, Vollenberg, Richard, Nowacki, Tobias Max
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8620225/
https://www.ncbi.nlm.nih.gov/pubmed/34833096
http://dx.doi.org/10.3390/life11111220

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8620225/
https://www.ncbi.nlm.nih.gov/pubmed/34833096
http://dx.doi.org/10.3390/life11111220

Ejemplares similares